CIK: 0001017645 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 14, 2025
Total Value ($000): $2,979,034 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALHC | ALIGNMENT HEALTHCARE | 60,993,323 | $1,135,696 | 38.1% | $19.55 | -23.7% | COM | 01625V104 |
| DLO | DLOCAL | 63,906,695 | $532,982 | 17.9% | $34.47 | -68.9% | CL A | G29018101 |
| XP | XP, INC | 29,617,733 | $407,244 | 13.7% | $31.26 | -56.0% | CL A | G98239109 |
| ALKT | ALKAMI | 9,645,318 | $253,190 | 8.5% | $36.66 | -14.1% | COM | 01644J108 |
| — | AKERO THERAPEUTICS | 5,233,989 | $211,872 | 7.1% | $32.57 | — | COM | 00973Y108 |
| CNTA | CENTESSA PHARMACEUTICALS | 9,681,818 | $139,225 | 4.7% | $17.55 | — | ADS | 152309100 |
| PHVS | PHARVARIS | 7,531,252 | $118,241 | 4.0% | $22.20 | -24.0% | COM | N69605108 |
| EWCZ | EUROPEAN WAX CENTER | 13,110,492 | $51,786 | 1.7% | $22.36 | -73.4% | CL A | 29882P106 |
| RPRX | ROYALTY PHARMA | 1,500,000 | $46,695 | 1.6% | $49.50 | -36.0% | CL A | G7709Q104 |
| IMCR | IMMUNOCORE | 1,261,684 | $37,434 | 1.3% | $50.86 | — | ADS | 45258D105 |
| RSKD | RISKIFIED | 5,324,998 | $24,601 | 0.8% | $28.06 | -82.0% | CL A | M8216R109 |
| — | ACELYRIN | 2,695,327 | $6,657 | 0.2% | $15.74 | — | COM | 00445A100 |
| ADAG | ADAGENE | 3,825,952 | $5,815 | 0.2% | $3.09 | — | ADS | 005329107 |
| — | WISH | 609,616 | $4,255 | 0.1% | $6.58 | — | CL A | 21077C305 |
| GROV | GROVE COLLABORATIVE | 2,474,859 | $3,341 | 0.1% | $1.69 | -8.5% | CL A | 39957D201 |